US 9603853
Formulations of viloxazine
granted A61KA61K31/5375A61K9/00
Quick answer
US patent 9603853 (Formulations of viloxazine) held by Supernus Pharmaceuticals, Inc. expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/5375, A61K9/00, A61K9/146, A61K9/2054